Dapagliflozin suppresses cardiovascular events in patients with chronic heart failure, type 2 diabetes mellitus: Study
The DAPPER study was conducted with the National Cardiovascular Center as the principal investigator, with 294 patients participating from 18 facilities in Japan. In this study, researchers investigated whether dapagliflozin ...
Nov 27, 2023
0
1